Natixis’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,055
| Closed | -$2.78M | – | 1104 |
|
|
2024
Q1 | $2.78M | Sell |
14,055
-2,937
| -17% | -$582K | 0.01% | 377 |
|
|
2023
Q4 | $2.92M | Sell |
16,992
-201,882
| -92% | -$34.7M | 0.02% | 341 |
|
|
2023
Q3 | $32.4M | Buy |
218,874
+217,951
| +23,613% | +$32.2M | 0.25% | 82 |
|
|
2023
Q2 | $202K | Buy |
+923
| New | +$202K | ﹤0.01% | 725 |
|
|
2023
Q1 | – | Sell |
-220,203
| Closed | -$45.8M | – | 1105 |
|
|
2022
Q4 | $45.8M | Buy |
220,203
+211,185
| +2,342% | +$44M | 0.26% | 93 |
|
|
2022
Q3 | $1.97M | Buy |
9,018
+2,662
| +42% | +$581K | 0.01% | 582 |
|
|
2022
Q2 | $1.33M | Buy |
+6,356
| New | +$1.33M | ﹤0.01% | 718 |
|
|
2022
Q1 | – | Sell |
-70,053
| Closed | -$18.2M | – | 1307 |
|
|
2021
Q4 | $18.2M | Buy |
70,053
+30,326
| +76% | +$7.9M | 0.06% | 258 |
|
|
2021
Q3 | $10.5M | Buy |
+39,727
| New | +$10.5M | 0.04% | 356 |
|
|
2021
Q2 | – | Sell |
-2,725
| Closed | -$529K | – | 956 |
|
|
2021
Q1 | $529K | Sell |
2,725
-25,543
| -90% | -$4.96M | ﹤0.01% | 932 |
|
|
2020
Q4 | $6.01M | Buy |
28,268
+18,543
| +191% | +$3.94M | 0.02% | 482 |
|
|
2020
Q3 | $1.67M | Buy |
9,725
+5,583
| +135% | +$957K | 0.01% | 450 |
|
|
2020
Q2 | $795K | Buy |
+4,142
| New | +$795K | 0.01% | 555 |
|
|
2019
Q2 | – | Sell |
-20,451
| Closed | -$2.1M | – | 871 |
|
|
2019
Q1 | $2.1M | Buy |
20,451
+4,571
| +29% | +$469K | 0.01% | 493 |
|
|
2018
Q4 | $1.81M | Sell |
15,880
-679
| -4% | -$77.3K | 0.01% | 441 |
|
|
2018
Q3 | $1.91M | Buy |
16,559
+432
| +3% | +$49.8K | 0.01% | 485 |
|
|
2018
Q2 | $1.67M | Sell |
16,127
-12,080
| -43% | -$1.25M | 0.01% | 548 |
|
|
2018
Q1 | $2.77M | Buy |
28,207
+17,660
| +167% | +$1.73M | 0.02% | 461 |
|
|
2017
Q4 | $893K | Buy |
+10,547
| New | +$893K | 0.01% | 518 |
|
|
2017
Q3 | – | Sell |
-10,208
| Closed | -$795K | – | 1346 |
|
|
2017
Q2 | $795K | Sell |
10,208
-109
| -1% | -$8.49K | 0.01% | 442 |
|
|
2017
Q1 | $743K | Buy |
10,317
+4,023
| +64% | +$290K | 0.01% | 446 |
|
|
2016
Q4 | $391K | Buy |
+6,294
| New | +$391K | ﹤0.01% | 569 |
|